Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
5
5 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- SKB264MK-2870, Sacituzumab TirumotecanPhase 353 trials
Merck & Co. · Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Cervical Cancer
- TNM001Phase 32 trials
Zhuhai Trinomab Pharmaceutical Co., Ltd. · Respiratory Syncytial Virus Infections
- EDP167Phase 22 trials
Eddingpharm (Zhuhai) Co., Ltd. · Mixed Dyslipidemia, Homozygous Familial Hypercholesterolemia (HoFH)
- GB268Phase 21 trial
Eddingpharm (Zhuhai) Co., Ltd. · Breast Cancer (Locally Advanced or Metastatic)
- GST101Phase 21 trial
Genuine Seed Therapeutics (Zhuhai) Co., Ltd. · RAS-mutant Advanced Solid Tumors
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.